PTCT - PTC Therapeutics issues EU US regulatory updates on Translarna
2023-12-05 17:53:48 ET
More on PTC Therapeutics
- PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript
- PTC Therapeutics stock slides after Citi downgrades to Sell
- PTC Therapeutics GAAP EPS of -$1.76 misses by $0.70, revenue of $196.6M misses by $15.07M
- Seeking Alpha’s Quant Rating on PTC Therapeutics
- Historical earnings data for PTC Therapeutics
For further details see:
PTC Therapeutics issues EU, US regulatory updates on Translarna